Refine your search

Search Results

Here are the studies that match your search criteria. If you are interested in participating, please reach out to the contact listed for the study. If no contact is listed, contact us and we'll help you find the right person.

1 Study Matches

A Phase III, Randomized, Open-Label Active Comparator-Controlled Multicenter Study to Evaluate Efficacy and Safety of Obinutuzumab in Patients with Primary Membranous Nephropathy

To evaluate the effectiveness and safety of obinutuzumab compared to tacrolimus in patients with primary membranous nephropathy
All
18 year(s) or older
This study is NOT accepting healthy volunteers
NCT04629248
Show full eligibility criteria
Hide eligibility criteria
Inclusion Criteria:
diagnosis of primary membranous nephropathy
age 18-75
ability to comply with requried study procedures
stable blood pressure
Exclusion Criteria:
secondary cause of membranous nephropathy
uncontrolled blood pressure
kidney transplant or dialysis
Type 1 or type 2 diabetes
Kidney & Urinary System
  Email this study information to me
  Contact the study team
  See more information
  Show all 1 locations

Study Locations

Hide all locations
Location
Hershey, PA